ACHV Stock Price | Achieve Life Sciences Inc P/E, Revenue, EPS, & Forecasts

Achieve Life Sciences Inc • ACHV

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Achieve Life Sciences Inc

Ticker

ACHV

Trading on

NASDAQ

ISIN

US0044685008

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Richard A. B. Stewart

Headquarters

1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1

Employees

Website

achievelifesciences.com

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Metrics

BasicAdvanced

Market cap

$99.2M

P/E ratio

EPS

-$1.24

Dividend Yield

0.00%

Beta

1.68

Forward P/E ratio

EBIDTA

$-38.8M

Ex dividend date

Price & volume

Market cap

$99.2M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

4.75

Earnings

EPS

-$1.24

EPS estimate (current quarter)

-$0.36

EPS estimate (next quarter)

-$0.35

EBITDA

$-38.8M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.68

52-week High

$5.59

52-week Low

$2.51

50-day moving average

$3.08

200-day moving average

$4.19

Short ratio

18.12

Short %

11.36%

Management effectiveness

ROE (TTM)

409.51%

ROA (TTM)

84.20%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

34.7M

Float

29.4M

Insiders %

9.77%

Institutions %

57.18%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 8 analysts.

Average price target

$16.44

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.26

-$0.24

8.33%

Q1 • 24Beat

-$0.25

-$0.23

8.70%

Q2 • 24Beat

-$0.36

-$0.26

38.46%

Q3 • 24Beat

-$0.36

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-12.5M

∞%

Q3 • 24

$0M

$-12.4M

∞%

Q4 • 24

NaN%

1.21%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$47.9M

$16.5M

34.52%

Q3 • 24

$38.6M

$17.7M

45.90%

Q4 • 24

19.38%

7.23%

32.99%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-10.4M

$13.3M

$-8.1M

$-10.4M

Q3 • 24

$-9.2M

$11.7M

$0.7M

$-9.2M

Q4 • 24

11.41%

11.71%

108.41%

11.41%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Achieve Life Sciences Inc share?

Achieve Life Sciences Inc shares are currently traded for undefined per share.

How many shares does Achieve Life Sciences Inc have?

Achieve Life Sciences Inc currently has 34.7M shares.

Does Achieve Life Sciences Inc pay dividends?

No, Achieve Life Sciences Inc doesn't pay dividends.

What is Achieve Life Sciences Inc 52 week high?

Achieve Life Sciences Inc 52 week high is $5.59.

What is Achieve Life Sciences Inc 52 week low?

Achieve Life Sciences Inc 52 week low is $2.51.

What is the 200-day moving average of Achieve Life Sciences Inc?

Achieve Life Sciences Inc 200-day moving average is $4.19.

Who is Achieve Life Sciences Inc CEO?

The CEO of Achieve Life Sciences Inc is Dr. Richard A. B. Stewart.

How many employees Achieve Life Sciences Inc has?

Achieve Life Sciences Inc has 25 employees.

What is the market cap of Achieve Life Sciences Inc?

The market cap of Achieve Life Sciences Inc is $99.2M.

What is the P/E of Achieve Life Sciences Inc?

The current P/E of Achieve Life Sciences Inc is null.

What is the EPS of Achieve Life Sciences Inc?

The EPS of Achieve Life Sciences Inc is -$1.24.

What is the PEG Ratio of Achieve Life Sciences Inc?

The PEG Ratio of Achieve Life Sciences Inc is 0.

What do analysts say about Achieve Life Sciences Inc?

According to the analysts Achieve Life Sciences Inc is considered a buy.